OpenAI Launches GPT-5.6
OpenAI is launching a limited rollout of its GPT-5.6 lineup, introducing three tiers, including the flagship model Sol, with a wider release expected in the coming weeks
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
7 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
OpenAI is launching a limited rollout of its GPT-5.6 lineup, introducing three tiers, including the flagship model Sol, with a wider release expected in the coming weeks
Anthropic's Economic Index reveals increasing use of autonomous AI agents for complex tasks, with users expecting AI to handle more workload in the next year
AbbVie acquires Apogee Therapeutics in a $10.9 billion cash deal, expanding its immunology pipeline
CRH is acquiring Arcosa, a leading US provider of aggregates and critical infrastructure products, for $8.5 billion
AbbVie is acquiring Apogee for $135.11 per share in cash to expand its pipeline of clinical-stage candidates for inflammatory and immunological diseases
AbbVie is acquiring Apogee Therapeutics to deepen its immunology portfolio
Abbvie is acquiring Apogee Therapeutics in a deal valuing Apogee at $10.9 billion